120例脑出血术前应用咪达唑仑的临床观察
2015-01-31周健
周健
120例脑出血术前应用咪达唑仑的临床观察
周健
【摘要】目的探讨120例脑出血术前应用咪达唑仑麻醉对术后复发再出血的影响以及麻醉安全性。方法 240例脑出血患者按照麻醉方法的不同分为各120例的观察组和对照组,对照组应用地西泮麻醉方案,观察组在一般麻醉的基础上给予咪达唑仑麻醉。对比分析两组之间的再出血发生率以及不良反应。结果 两组术前观察组HR、MAP变化和CEO2比较无统计学差异,术中、术后观察组HR、MAP变化和CEO2优于对照组,差异具有统计学意义(P<0.05)。观察组追加时间长于对照组,苏醒时间短于对照组,差异具有统计学意义(P<0.05)。观察组再出血比率低于对照组,差异具有统计学意义(P<0.05),本组研究对象,无一例麻醉安全事故发生。结论 脑出血术前应用咪达唑仑麻醉,效果良好,能够有效降低患者再出血的发生率,安全性较高。【关键词】脑出血;咪达唑仑;地西泮
作者单位: 474500 河南省南阳市西峡县人民医院
Clinical Observation of 120 Cases of Cerebral Hemorrhage Preoperative Application of Midazolam
ZHOU Jian, People's Hospital of Xixia County in Nanyang City, Henan Province, Nanyang 474500, China
[Abstract]Objective To discuss the effect of midazolam anesthesia on rebleeding of 120 cases of cerebral hemorrhage and the safety of anesthesia. Methods 240 patients with cerebral hemorrhage were divided into 120 groups according to different methods of anesthesia. Control group received conventional anesthesia, observation group accepted midazolam anesthesia on basis of general anesthesia. The incidence of rebleeding and adverse reactions between the two groups were compared and analyzed. Results Two groups of preoperative observation group HR, MAP changes and CEO2is no statistical difference, intraoperative and postoperative observation group HR, MAP, change and CEO2is better than that of control group, difference has statistical significance(P<0.05). Observation group of additional time is longer than the control group, awakening time shorter than the control group, the difference statistically significant(P<0.05). Observation group and bleeding ratio is lower than the control group, the difference statistically significant(P<0.05), the research had no anesthesia safety accidents. Conclusion The application of midazolam before cerebral hemorrhage can effectively reduce the incidence of rebleeding, and the safety is high.
[Key words]Cerebral hemorrhage, Midazolam, Propofol
脑出血(cerebral hemorrhage)患者因发生于脑部,发病急,严重脑出血患者具有较高的致死率和致残率,多采用手术治疗,在麻醉的过程中,麻醉效果及安全性至关重要[1]。此外,脑出血患者发生再出血是导致不良预后甚至死亡的重要原因,而再出血与麻醉苏醒速度、患者情绪等多因素相关[2]。本文以2012年1月~2014年12月于本院确诊为脑出血并进行手术治疗的240例患者为研究对象,现报告如下。
1 资料与方法
1.1一般资料
选择2012年1月~2014年12月于本院确诊为脑出血并进行
手术治疗的患者240例,按GCS评分3~11分,所有患者均无外伤史,脑出血量30~90 ml。……
